| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Maraviroc |
|---|
| Description | Selective CCR5 antagonist; displays potent anti-HIV-1 activity. Prevents the interaction of HIV-1 gp120 and CCR5 (IC50 = 6.4 nM), inhibiting HIV-1 entry. Exhibits antinociceptive effects in a rat model of neuropathic pain. Also inhibits CCL3 (MIP-1α) binding to CCR5. Orally bioavailable. Purity 99%. MW (observed): 513.67 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4,4-Difluoro-N-{(1S)-3-[3-(3-isopropyl- 5-methyl-4H-1,2,4-triazol-4-yl)- 8-azabicyclo[3.2.1]oct-8-yl]-1- phenylpropyl}cyclohexanecarboxamide. UK-427857 |
|---|
| Gene, Accession, CAS # | CAS: 376348-65-1 |
|---|
| Catalog # | 3756/50 |
|---|
| Price | |
|---|
| Order / More Info | Maraviroc from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 25712213, 26511387, 27117708, 29760499 |
|---|
| 產(chǎn)品資料 |
|
|